Showing 14,381 - 14,400 results of 34,259 for search '(( 50 ((nn decrease) OR (((teer decrease) OR (a decrease)))) ) OR ( 5 point decrease ))', query time: 1.03s Refine Results
  1. 14381

    PCAIs inhibit NCI-H23 cell line viability. by Matthew D. Gregory (19929096)

    Published 2024
    “…Of the 17 PCAIs tested, compounds NSL-YHJ-2-27 and NSL-YHJ-2-46 showed the most potency with EC<sub>50</sub> values of 2.7 and 3.3 μM, respectively. …”
  2. 14382

    PCAIs disrupt actin filaments in NCI-H23 cells. by Matthew D. Gregory (19929096)

    Published 2024
    “…Of the 17 PCAIs tested, compounds NSL-YHJ-2-27 and NSL-YHJ-2-46 showed the most potency with EC<sub>50</sub> values of 2.7 and 3.3 μM, respectively. …”
  3. 14383

    PCAIs suppress 3D NCI-H23 cell invasion. by Matthew D. Gregory (19929096)

    Published 2024
    “…Of the 17 PCAIs tested, compounds NSL-YHJ-2-27 and NSL-YHJ-2-46 showed the most potency with EC<sub>50</sub> values of 2.7 and 3.3 μM, respectively. …”
  4. 14384

    PCAIs suppress NCI-H23 cancer cell migration. by Matthew D. Gregory (19929096)

    Published 2024
    “…Of the 17 PCAIs tested, compounds NSL-YHJ-2-27 and NSL-YHJ-2-46 showed the most potency with EC<sub>50</sub> values of 2.7 and 3.3 μM, respectively. …”
  5. 14385

    PCAIs induce apoptosis in NCI-H23 cells. by Matthew D. Gregory (19929096)

    Published 2024
    “…Of the 17 PCAIs tested, compounds NSL-YHJ-2-27 and NSL-YHJ-2-46 showed the most potency with EC<sub>50</sub> values of 2.7 and 3.3 μM, respectively. …”
  6. 14386

    Prevaelnce of different pathogens by location. by Amete Mihret Teshale (12072758)

    Published 2025
    “…<div><p>Diarrheal illness remains a major global health challenge, causing millions of deaths annually. …”
  7. 14387

    File S1 - Modifications in Rat Plasma Proteome after Remote Ischemic Preconditioning (RIPC) Stimulus: Identification by a SELDI-TOF-MS Approach by Pierre Hibert (470627)

    Published 2014
    “…Detailed <i>p-</i>value data for comparison between the three groups is indicated in <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0085669#pone-0085669-t002" target="_blank">Table 2</a>. …”
  8. 14388
  9. 14389
  10. 14390
  11. 14391
  12. 14392
  13. 14393

    Effects of ROS scavenging on the counteraction of EMT-like process due to <i>K</i>. <i>pneumoniae</i> infection of A549 cells. by Laura Leone (297477)

    Published 2016
    “…<p>The A549 cells were pretreated for 12h before the infection with the resveratrol 50 μM. …”
  14. 14394
  15. 14395

    Image_3_Clinical Outcomes and Complications of Preoperative Embolization for Intracranial Giant Meningioma Tumorectomy: A Retrospective, Observational, Matched Cohort Study.tif by Yi Yin (448434)

    Published 2022
    “…We did not find any significant differences of estimated blood loss (600.00 (400) vs. 500.00 (500.00) ml, p = 0.31), decrease of HGB level (30.81 ± 15.82 vs. 26.59 ± 12.90 g/L, p = 0.09), gross total resection rate (74.24% vs. 77.27%, p = 0.68), surgical time (302.50 (136) vs. 300.00 (72) min, p = 0.48), blood transfusion rates (53.03% vs. 42.42%, p = 0.35), blood transfusion volume [650.00 (657.50) vs. 535.00 (875.00) ml, p = 0.63] between the embolization group and nonembolization group. …”
  16. 14396
  17. 14397

    Image_1_Clinical Outcomes and Complications of Preoperative Embolization for Intracranial Giant Meningioma Tumorectomy: A Retrospective, Observational, Matched Cohort Study.tif by Yi Yin (448434)

    Published 2022
    “…We did not find any significant differences of estimated blood loss (600.00 (400) vs. 500.00 (500.00) ml, p = 0.31), decrease of HGB level (30.81 ± 15.82 vs. 26.59 ± 12.90 g/L, p = 0.09), gross total resection rate (74.24% vs. 77.27%, p = 0.68), surgical time (302.50 (136) vs. 300.00 (72) min, p = 0.48), blood transfusion rates (53.03% vs. 42.42%, p = 0.35), blood transfusion volume [650.00 (657.50) vs. 535.00 (875.00) ml, p = 0.63] between the embolization group and nonembolization group. …”
  18. 14398

    Image_2_Clinical Outcomes and Complications of Preoperative Embolization for Intracranial Giant Meningioma Tumorectomy: A Retrospective, Observational, Matched Cohort Study.tif by Yi Yin (448434)

    Published 2022
    “…We did not find any significant differences of estimated blood loss (600.00 (400) vs. 500.00 (500.00) ml, p = 0.31), decrease of HGB level (30.81 ± 15.82 vs. 26.59 ± 12.90 g/L, p = 0.09), gross total resection rate (74.24% vs. 77.27%, p = 0.68), surgical time (302.50 (136) vs. 300.00 (72) min, p = 0.48), blood transfusion rates (53.03% vs. 42.42%, p = 0.35), blood transfusion volume [650.00 (657.50) vs. 535.00 (875.00) ml, p = 0.63] between the embolization group and nonembolization group. …”
  19. 14399

    Table_1_Clinical Outcomes and Complications of Preoperative Embolization for Intracranial Giant Meningioma Tumorectomy: A Retrospective, Observational, Matched Cohort Study.docx by Yi Yin (448434)

    Published 2022
    “…We did not find any significant differences of estimated blood loss (600.00 (400) vs. 500.00 (500.00) ml, p = 0.31), decrease of HGB level (30.81 ± 15.82 vs. 26.59 ± 12.90 g/L, p = 0.09), gross total resection rate (74.24% vs. 77.27%, p = 0.68), surgical time (302.50 (136) vs. 300.00 (72) min, p = 0.48), blood transfusion rates (53.03% vs. 42.42%, p = 0.35), blood transfusion volume [650.00 (657.50) vs. 535.00 (875.00) ml, p = 0.63] between the embolization group and nonembolization group. …”
  20. 14400